Sarcoidosis associated with vemurafenib

Authors

  • A. Adam,

    1. Unit of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre- Bénite, France
    2. Université Claude Bernard Lyon 1, Lyon, France
    Search for more papers by this author
  • L. Thomas,

    1. Unit of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre- Bénite, France
    2. Université Claude Bernard Lyon 1, Lyon, France
    Search for more papers by this author
  • N. Bories,

    1. Unit of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre- Bénite, France
    Search for more papers by this author
  • D. Zaharia,

    1. Unit of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre- Bénite, France
    2. Université Claude Bernard Lyon 1, Lyon, France
    Search for more papers by this author
  • B. Balme,

    1. Unit of Pathology and Unit of Pneumonology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
    Search for more papers by this author
  • N. Freymond,

    1. Unit of Pathology and Unit of Pneumonology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France
    Search for more papers by this author
  • S. Dalle

    Corresponding author
    1. Université Claude Bernard Lyon 1, Lyon, France
    2. Cancer Research Center of Lyon, 8 avenue de Rockefeller, 69008 Lyon, France
    • Unit of Dermatology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre- Bénite, France
    Search for more papers by this author

  • Funding sources: This work is supported in part by grants from Lyon 1 University (to L.T.), the Hospices Civils de Lyon (to L.T.) and the Ligue Contre le Cancer du Rhone (to L.T.).
  • Conflicts of interest: none declared.

Correspondence: Stéphane Dalle.

E-mail: stephane.dalle@chu-lyon.fr

No abstract is available for this article.

Ancillary